Evaluating end‐to‐end continuous antibody manufacture with column‐free capture alternatives from economic, environmental, and robustness perspectives

Documenti analoghi

• Advancing multiproduct resin reuse for development and clinical manufacturing of an antibody‐based therapeutic
  di: Hong Li, et al.
  Pubblicazione: (2024)
• A modular and multi‐functional purification strategy that enables a common framework for manufacturing scale integrated and continuous biomanufacturing
  di: Leon P. Pybus, et al.
  Pubblicazione: (2024)
• Triton CG ‐110 as an alternative for cell lysis in manufacturing of adeno‐associated virus ‐based gene therapy
  di: Yixuan Ming, et al.
  Pubblicazione: (2025)
• Use of live digital twin (shadow) soft sensor to monitor membrane degradation in continuous manufacturing single pass tangential flow filtration
  di: Robert Taylor, et al.
  Pubblicazione: (2025)
• Design of experiments‐guided membrane capture facilitates integration of continuous virus inactivation using Phi6 as a surrogate virus in an intensified downstream process
  di: Mario Grünberg, et al.
  Pubblicazione: (2026)